Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for prevention of cardiovascular events in hospitalized patients with pneumonia or influenza
NL-OMON59925Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in community-acquired pneumonia (CAP) and influenza, sponsored by Amsterdam University Medical Center. Primary endpoint: Incidence of acute coronary syndrome. Started Dec 2023; status: completed.
02
Drugs
aspirin
03
Conditions
community-acquired pneumonia (CAP)influenza
Beyond the preview
Go deeper on NL-OMON59925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59925.